insights_auto
Why is PGEN down ၁၁.၂၆%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
၆.၃၈ US$
arrow_downward
-၁၁.၂၆%(-၀.၈၁) 1D
၆.၄၆ US$
arrow_upward
+၁.၁၇% (+၀.၀၇၅)bedtimeAfter hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
၇.၁၉ US$
High
၇.၂၂ US$
Low
၆.၃၀ US$
Mkt. cap
၂၂၈.၆၁ ဋေ
Avg. vol.
၄.၇၇ သန်း
Volume
၅.၄၉ သန်း
52-wk high
၈.၉၈ US$
52-wk low
၃.၀၄ US$
EPS
-၁.၁၀ US$
Beta
၀.၉၂
Shares outstanding
၃၅.၈၀ ကုဋေ
No. of employees
၁၆၀
Open
၇.၁၉ US$
High
၇.၂၂ US$
Low
၆.၃၀ US$
Mkt. cap
၂၂၈.၆၁ ဋေ
Avg. vol.
၄.၇၇ သန်း
Volume
၅.၄၉ သန်း
52-wk high
၈.၉၈ US$
52-wk low
၃.၀၄ US$
EPS
-၁.၁၀ US$
Beta
၀.၉၂
Shares outstanding
၃၅.၈၀ ကုဋေ
No. of employees
၁၆၀
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၅ မိနစ်
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
Law360
·
ပြီးခဲ့သည့် ၁ နာရီ
Nasdaq Sued Over Delisting Of Social Media Co.
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc